News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
270,617 Results
Type
Article (14024)
Company Profile (299)
Press Release (256294)
Section
Business (82258)
Career Advice (156)
Deals (13515)
Drug Delivery (34)
Drug Development (51325)
Employer Resources (31)
FDA (6188)
Job Trends (5201)
News (149082)
Policy (10384)
Tag
Academia (914)
Alliances (22141)
Alzheimer's disease (754)
Approvals (6161)
Artificial intelligence (69)
Bankruptcy (104)
Best Places to Work (4573)
Biotechnology (246)
Breast cancer (111)
Cancer (874)
Cardiovascular disease (68)
Career advice (136)
CAR-T (68)
Cell therapy (208)
Clinical research (40960)
Collaboration (285)
Compensation (121)
COVID-19 (1018)
C-suite (77)
Cystic fibrosis (66)
Data (975)
Diabetes (83)
Diagnostics (1300)
Earnings (30914)
Events (47986)
Executive appointments (228)
FDA (6541)
Funding (295)
Gene editing (63)
Gene therapy (162)
GLP-1 (307)
Government (1079)
Healthcare (6657)
Infectious disease (1054)
Inflammatory bowel disease (98)
IPO (7309)
Job creations (892)
Job search strategy (131)
Layoffs (186)
Legal (1425)
Lung cancer (123)
Lymphoma (57)
Manufacturing (79)
Medical device (2771)
Medtech (2772)
Mergers & acquisitions (6322)
Metabolic disorders (245)
Neuroscience (997)
NextGen Class of 2024 (2040)
Non-profit (853)
Northern California (1063)
Obesity (135)
Opinion (91)
Parkinson's disease (70)
Patents (59)
People (25331)
Phase I (14245)
Phase II (18924)
Phase III (12250)
Pipeline (358)
Postmarket research (928)
Preclinical (6023)
Radiopharmaceuticals (207)
Rare diseases (196)
Real estate (1458)
Regulatory (8567)
Research institute (943)
Southern California (955)
Startups (1991)
United States (8492)
Vaccines (164)
Weight loss (78)
Date
Last 7 days (439)
Last 30 days (1449)
Last 365 days (20784)
2024 (20336)
2023 (22644)
2022 (27090)
2021 (28148)
2020 (23683)
2019 (16508)
2018 (11969)
2017 (14083)
2016 (12057)
2015 (14637)
2014 (10605)
2013 (7654)
2012 (7803)
2011 (8046)
2010 (7899)
Location
Africa (148)
Asia (17357)
Australia (2958)
California (2408)
Canada (807)
China (194)
Colorado (89)
Connecticut (100)
Europe (37565)
Florida (265)
Georgia (68)
Illinois (148)
Indiana (63)
Kansas (55)
Maryland (320)
Massachusetts (1906)
Michigan (57)
Minnesota (101)
New Jersey (614)
New York (667)
North Carolina (417)
Northern California (1063)
Ohio (81)
Pennsylvania (471)
South America (212)
Southern California (955)
Texas (277)
Washington State (245)
270,617 Results for "tm3 therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Protagonist Therapeutics Ranked in the Top 3% of Fastest-Growing Companies in North America on the 2023 Deloitte Technology Fast 500(TM)
Protagonist Therapeutics announced it ranked in the top 3% of the 2023 Deloitte Technology Fast 500TM, a list of the fastest-growing technology, media, telecommunications, life sciences, fintech and energy tech companies in North America.
November 9, 2023
·
5 min read
News
POP Biotechnologies Announces Phase 3 Trial Interim Results Published for COVID-19 Vaccine Based on POP BIO SNAP(TM)
September 27, 2024
·
3 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
BioCapital
Elixirgen Therapeutics Presents Preclinical Data with Bobcat mRNATM Technology in Duchenne Muscular Dystrophy at the 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Elixirgen Therapeutics, Inc., today presented preclinical data on its proprietary Bobcat mRNA TM technology in a poster presentation at the 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference taking place March 3-6, 2024, in Orlando, Florida.
March 4, 2024
·
2 min read
Regulatory
FDA Warns Applied Therapeutics of ‘Objectionable Conditions’ in Govorestat Study
The agency’s warning letter outlines Applied Therapeutics’ failure to provide adequate information regarding the clinical trial—including a dosing error for govorestat—claims that the company said it had already addressed.
December 4, 2024
·
2 min read
·
Tristan Manalac
Press Releases
NeuroEM Therapeutics(R) Accepted into StartUp Health’s Alzheimer’s Moonshot Community(TM)
September 19, 2024
·
4 min read
Press Releases
Join Enlivex Therapeutics’ Exclusive Live Investor Webinar and Q&A Session on December 3
November 27, 2024
·
3 min read
Complete response letters
Applied Therapeutics Crashes After FDA Rejection of Rare Disease Drug
After extending its review period to evaluate additional submissions, the FDA ultimately denied Applied Therapeutics’ govorestat for galactosemia, citing “deficiencies” with the application. The biotech plans to meet with the regulator to discuss the best way forward for the drug.
December 2, 2024
·
3 min read
·
Tristan Manalac
Layoffs
Spero Therapeutics to Lay Off 39% of Employees
Following disappointing results for an antibiotic candidate whose development program is now being suspended, Spero Therapeutics is looking to extend its cash runway while it focuses on other assets in its pipeline.
October 30, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Havah Therapeutics to Present Real World Data at the RiseUp for Breast Cancer Conference
October 30, 2024
·
1 min read
1 of 27,062
Next
